HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THEN-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID)-Reference-Cited by-同舟云学术

HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THEN-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID)

Published:2005-08-23 Issue:11 Volume:33 Page:1740-1747
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Clement Bernd,Mau Sabine,Deters Stephanie,Havemeyer Antje

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference42 articles.

1. Probing the Differences between Rat Liver Outer Mitochondrial Membrane Cytochrome b5 and Microsomal Cytochromes b5

2. CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OFN-HYDROXYMELAGATRAN AND BENZAMIDOXIME

3. Reduction of hydroxylamine by rat liver mitochondria

4. Distribution of the integral membrane protein NADH-cytochrome b5 reductase in rat liver cells, studied with a quantitative radioimmunoblotting assay

5. Clement B (1993) inventor. Methoden zur Behandlung und Prophylaxe der Pneumocystis carinii pneumonie (PCP) und anderen Erkrankungen sowie Verbindungen und Formulierungen zum Gebrauch bei besagten Methoden. German patent P 4321444.4, PCT/DE 94/00756 (1994); U.S. patent 5,786,383 (1998 July 28); European patent 0708640 (1998 September 16).

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target;Journal of Biological Chemistry;2023-11

2. New Design of an Activity Assay Suitable for High-Throughput Screening of Substrates and Inhibitors of the Mitochondrial Amidoxime Reducing Component (mARC);Analytical Chemistry;2023-08-07

3. The History of mARC;Molecules;2023-06-12

4. Evaluation of amidoxime derivatives as prodrug candidates of potent bis-cationic antimalarials;Bioorganic & Medicinal Chemistry Letters;2019-08

5. Inhibitors of the Growth-Factor Activating Proteases Matriptase, Hepsin and HGFA: Strategies for Rational Drug Design and Optimization;Extracellular Targeting of Cell Signaling in Cancer;2018-05-11